Commonwealth Equity Services, LLC Vir Biotechnology, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 68,835 shares of VIR stock, worth $509,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,835

Previous 63,235 8.86%

Holding current value

$509,379

Previous $563,000 8.35%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$7.26 - $10.7 $40,656 - $59,919	5,600 Added 8.86%	68,835 $516,000
Q2 2024 Jul 31, 2024	SELL	$7.63 - $12.66 $23,523 - $39,030	-3,083 Reduced 4.65%	63,235 $563,000
Q1 2024 Apr 29, 2024	SELL	$8.6 - $11.9 $860 - $1,190	-100 Reduced 0.15%	66,318 $672,000
Q4 2023 Feb 06, 2024	SELL	$7.76 - $10.29 $7,946 - $10,536	-1,024 Reduced 1.52%	66,418 $668,000
Q3 2023 Oct 23, 2023	SELL	$9.14 - $24.62 $21,405 - $57,660	-2,342 Reduced 3.36%	67,442 $632,000
Q1 2023 May 11, 2023	SELL	$22.26 - $30.85 $208,887 - $289,496	-9,384 Reduced 11.85%	69,784 $1.62 Million
Q4 2022 Feb 07, 2023	SELL	$19.96 - $28.22 $122,354 - $172,988	-6,130 Reduced 7.19%	79,168 $2 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $9,549 - $16,265	523 Added 0.62%	85,298 $1.64 Million
Q1 2022 May 04, 2022	SELL	$21.19 - $40.01 $17,905 - $33,808	-845 Reduced 0.99%	84,775 $2.18 Million
Q4 2021 Jan 31, 2022	SELL	$30.97 - $54.03 $50,202 - $87,582	-1,621 Reduced 1.86%	85,620 $3.58 Million
Q3 2021 Oct 29, 2021	SELL	$34.9 - $54.54 $805,771 - $1.26 Million	-23,088 Reduced 20.93%	87,241 $3.8 Million
Q2 2021 Aug 11, 2021	BUY	$38.75 - $51.0 $809,913 - $1.07 Million	20,901 Added 23.37%	110,329 $5.22 Million
Q1 2021 May 04, 2021	SELL	$26.34 - $83.07 $1.51 Million - $4.77 Million	-57,376 Reduced 39.08%	89,428 $4.58 Million
Q4 2020 Feb 11, 2021	SELL	$25.51 - $43.38 $13,112 - $22,297	-514 Reduced 0.35%	146,804 $3.93 Million
Q3 2020 Nov 05, 2020	SELL	$28.28 - $53.6 $342,781 - $649,685	-12,121 Reduced 7.6%	147,318 $5.06 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $4.45 Million - $7.63 Million	159,439 New	159,439 $6.53 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Vir Biotechnology, Inc. Transaction History